Home > Insider Trading > Filing (0001213900-25-047511)

Filing Details

Accession Number:: 0001213900-25-047511
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-23 21:30:24
Reporting Period:: 2025-05-21

Filing Date:: 2025-05-23
Accepted Time:: 2025-05-23 21:30:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1979414	Neonc Technologies Holdings Inc.	NTHI	Pharmaceutical Preparations (2834)	921954864

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1998682	C Thomas Chen	23975 Sorrento Park Suite 205 Calabasas CA 91302	Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-21	2,759	$7.25	548,959	No	4	P	Direct
Common Stock	Acquisiton	2025-05-22	2,709	$7.38	551,668	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	261,242	Indirect	By HCWG LLC.
Common Stock	888,148	Indirect	By NeuCen Biomedical Co. Ltd.
Common Stock	2,833,961	Indirect	By TR Chen Third Family Limited Partnership.
Common Stock	93,253	Indirect	By Tien Duan Chen Trust.

Footnotes

The aggregate number of shares of Issuer's Class A common stock (the "Shares") purchased by the Reporting Person on the same day at different prices.
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $7.181 to $7.25 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $7.38 to $7.4899 per share. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
Such shares represent only Reporting Person's percentage interest in HCWG LLC.
Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.